They explain this in the preso. Revenue has been deferred to future periods due to the shut down of Crinum. They expect this will be resolved soon and revenue will flow through in FY23 which is why guidance is at 700+ Mill and EBITDA of 80+ Mill.
This is a year of investment and we shouldn’t expect any returns this year, however forecast going forward is good and we can expect dividends/buybacks
MYE discussion thread, page-23
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.98M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 16.5¢ | $4.335K | 25.74K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 28803 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 241098 | 3 |
View Market Depth
| Last trade - 11.53am 01/11/2024 (20 minute delay) ? |
| MYE (ASX) Chart |